2003
DOI: 10.1016/s0264-410x(02)00412-7
|View full text |Cite
|
Sign up to set email alerts
|

Construction and characterisation of O139 cholera vaccine candidates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0
1

Year Published

2005
2005
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 47 publications
0
12
0
1
Order By: Relevance
“…Most effort at developing vaccines against cholera has focused on the development of safe and effective vaccines for oral administration (Ledón et al, 2003;Liang et al, 2003). Earlier work with either killed whole-cell or liveattenuated V. cholerae showed that killed whole-cell vaccines administered orally were approximately 50% effective, similar to the efficacy observed previously with parenteral administration.…”
Section: Gastrointestinal Infections Choleramentioning
confidence: 74%
“…Most effort at developing vaccines against cholera has focused on the development of safe and effective vaccines for oral administration (Ledón et al, 2003;Liang et al, 2003). Earlier work with either killed whole-cell or liveattenuated V. cholerae showed that killed whole-cell vaccines administered orally were approximately 50% effective, similar to the efficacy observed previously with parenteral administration.…”
Section: Gastrointestinal Infections Choleramentioning
confidence: 74%
“…Southern blotting analyses were performed with the following digoxigenin (DIG)-labeled probes (Roche Diagnostics GmbH): a 1.5 kb PCR product spanning the region between gIII CTX and zot genes was used as CTX4 core-specific probe [28], a 643 bp fragment containing part of ctxAB genes amplified by PCR with the primer pairs 5 0 -ATG ATCATGCAA-GAGGAACTC-3 0 and 5 0 -AGGTGTTCCATGTGCATATG C-3 0 was used as the ctxAB-specific probe, the 2.9 kb EcoRI-PstI fragment containing the RS1 element from pURS1 was used as the RS-specific probe [29], the 3.2 kb HindIII insert of pCH 2 [30], containing hapA gene, was used as a hapA-specific probe and, finally, a 2.6 kb-fragment containing part of mshA gene and its flanking regions was used as mshA-specific probe [31].…”
Section: Molecular Methodsmentioning
confidence: 99%
“…1 Endoglucanase A activity in V. cholerae was detected as previously described [17]. For motility determination were used swarm agar plates as described elsewhere [31]. Bacterial strains were tested for their susceptibility to streptomycin at 100 mg/ml on LB plates and to sulfamethoxazole (23.75 mg) and trimethoprim (1.25 mg) (SXT) by the disc diffusion technique.…”
Section: Molecular Methodsmentioning
confidence: 99%
See 2 more Smart Citations